Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Laprie A, Michon J, Hartmann O, Munzer C, Leclair MD, Coze C, Valteau-Couanet D, Plantaz D, Carrie C, Habrand JL, Bergeron C, Chastagner P, Défachelles AS, Delattre O, Combaret V, Bénard J, Pérel Y, Gandemer V, Rubie H; Neuroblastoma Study Group of the French Society of Pediatric Oncology. Laprie A, et al. Among authors: defachelles as. Cancer. 2004 Sep 1;101(5):1081-9. doi: 10.1002/cncr.20453. Cancer. 2004. PMID: 15329919 Free article.
Shedding a Light on the Challenges of Adolescents and Young Adults with Rhabdomyosarcoma.
Ferrari A, Gatz SA, Minard-Colin V, Alaggio R, Hovsepyan S, Orbach D, Gasparini P, Defachelles AS, Casanova M, Milano GM, Chisholm JC, Jenney M, Bisogno G, Rogers T, Mandeville HC, Shipley J, Miah AB, Merks JHM, van der Graaf WTA. Ferrari A, et al. Among authors: defachelles as. Cancers (Basel). 2022 Dec 9;14(24):6060. doi: 10.3390/cancers14246060. Cancers (Basel). 2022. PMID: 36551545 Free PMC article. Review.
Oral vinorelbine in young patients with desmoid-type fibromatosis.
Kornreich L, Orbach D, Nicolas N, Brisse HJ, Berlanga P, Defachelles AS, Mansuy L, Verite C, Saumet L, Karanian M, Corradini N. Kornreich L, et al. Among authors: defachelles as. Tumori. 2023 Oct;109(5):511-518. doi: 10.1177/03008916231169806. Epub 2023 Apr 28. Tumori. 2023. PMID: 37114926
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.
Bourdeaut F, Ferrand S, Brugières L, Hilbert M, Ribeiro A, Lacroix L, Bénard J, Combaret V, Michon J, Valteau-Couanet D, Isidor B, Rialland X, Poirée M, Defachelles AS, Peuchmaur M, Schleiermacher G, Pierron G, Gauthier-Villars M, Janoueix-Lerosey I, Delattre O; Comité Neuroblastome of the Société Francaise de Cancérologie. Bourdeaut F, et al. Among authors: defachelles as. Eur J Hum Genet. 2012 Mar;20(3):291-7. doi: 10.1038/ejhg.2011.195. Epub 2011 Nov 9. Eur J Hum Genet. 2012. PMID: 22071890 Free PMC article.
Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma--a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE).
Minard-Colin V, Ichante JL, Nguyen L, Paci A, Orbach D, Bergeron C, Defachelles AS, André N, Corradini N, Schmitt C, Tabone MD, Blouin P, Sirvent N, Goma G, Geoerger B, Oberlin O. Minard-Colin V, et al. Among authors: defachelles as. Eur J Cancer. 2012 Oct;48(15):2409-16. doi: 10.1016/j.ejca.2012.04.012. Epub 2012 May 25. Eur J Cancer. 2012. PMID: 22633624 Clinical Trial.
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.
Owens C, Laurence V, Benboubker L, Defachelles AS, Cupissol D, Rubie H, Brisse H, Rey A, Ollivier L, Couanet D, Baunin C, Aït-Oukhatar CM, Oberlin O. Owens C, et al. Among authors: defachelles as. Cancer Chemother Pharmacol. 2013 Feb;71(2):399-404. doi: 10.1007/s00280-012-2015-7. Epub 2012 Nov 17. Cancer Chemother Pharmacol. 2013. PMID: 23161409 Clinical Trial.
Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94.
Ducassou A, Gambart M, Munzer C, Padovani L, Carrie C, Haas-Kogan D, Bernier-Chastagner V, Demoor C, Claude L, Helfre S, Bolle S, Leseur J, Huchet A, Rubie H, Valteau-Couanet D, Schleiermacher G, Coze C, Defachelles AS, Marabelle A, Ducassou S, Devalck C, Gandemer V, Munzer M, Laprie A; Neuroblastoma study group and radiotherapy group of the French Society of Children with Cancer (SFCE). Ducassou A, et al. Among authors: defachelles as. Strahlenther Onkol. 2015 Jul;191(7):604-12. doi: 10.1007/s00066-015-0837-z. Epub 2015 Apr 21. Strahlenther Onkol. 2015. PMID: 25896312 Clinical Trial.
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group. Pritchard-Jones K, et al. Lancet. 2015 Sep 19;386(9999):1156-64. doi: 10.1016/S0140-6736(14)62395-3. Epub 2015 Jul 9. Lancet. 2015. PMID: 26164096 Free article. Clinical Trial.
Risk of neuroblastoma, birth-related characteristics, congenital malformations and perinatal exposures: A pooled analysis of the ESCALE and ESTELLE French studies (SFCE).
Rios P, Bailey HD, Orsi L, Lacour B, Valteau-Couanet D, Levy D, Corradini N, Leverger G, Defachelles AS, Gambart M, Sirvent N, Thebaud E, Ducassou S, Clavel J. Rios P, et al. Among authors: defachelles as. Int J Cancer. 2016 Nov 1;139(9):1936-48. doi: 10.1002/ijc.30239. Epub 2016 Jul 13. Int J Cancer. 2016. PMID: 27342419
92 results